查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1458406

全球乳房重建市場：依產品、依程序、依最終用戶、依地區、機會、預測，2017-2031 年

Breast Reconstruction Market Assessment, By Product, By Procedure, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 225 Pages | 商品交期: 3-5個工作天內

價格

全球乳房重建市場規模預計將從2023年的10.1億美元增長到2031年的15.1億美元，在2024-2031年的預測期內複合年增長率為5.14%。近年來，市場經歷了顯著成長，預計未來將保持強勁的擴張速度。全球乳房重建市場的成長受到多種因素的推動，例如全球人口中乳癌盛行率的上升以及全球乳房重建手術數量的增加。技術進步、醫療保健產業（包括醫療器材產業和外科產業）的成長以及公共和私人組織提高意識活動是促使全球該市場成長的因素。此外，有利的監管制度和報銷政策、多家頂級公司的存在和合資活動、新進入者以及頻繁的產品發佈正在加速全球乳房再造市場的成長。

全球乳房重建市場正在強勁成長，這主要是由於全球人口中乳癌盛行率的上升。隨著這種盛行率的增加，每年進行的乳房切除術的數量也隨之增加。乳房再造是乳房切除術後恢復乳房形狀、大小、對稱性和輪廓的重要步驟。該行業的技術進步，例如使用人工智慧進行乳房重建，主要參與者增加研發活動，正在進一步加速全球乳房重建市場的發展。

市場進入者頻繁推出產品以及有利的監管框架在推動全球乳房重建市場方面發揮關鍵作用。FDA 對乳房植入物的批准不斷增加，從而改善了患者的醫療狀況和手術結果。此外，併購、合作夥伴關係和組織間分銷協議等持續的合作活動進一步推動了全球乳房再造市場的發展。

該報告研究了全球乳房重建市場，並提供了市場概述，包括依產品、程序、最終用戶、地區和參與市場的公司概況劃分的趨勢。

目錄

第一章研究方法論

第二章 專案範圍與定義

第三章執行摘要

第四章 2017-2031 年全球乳房重建市場展望

  • 市場規模及預測
  • 依程式
  • 依產品
  • 依最終用戶
  • 依地區
  • 依公司劃分的市佔率 (%)，2023 年

第五章全球乳房重建市場展望（依地區，2017-2031）

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東/非洲

第六章 2023 年市場規劃

第七章 宏觀環境與產業結構

  • 供需分析
  • 進出口分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第八章市場動態

第九章 監理架構與創新

第十章 主要與企業狀況

第11章價格分析

第十二章案例研究

第十三章 主要進入者展望

  • Allergan Aesthetics
  • Sientra, Inc.
  • Medical Devices Business Services, Inc.
  • RTI Surgical, Inc.
  • Groupe SEBBIN SAS
  • Integra LifeSciences
  • GC Aesthetics
  • Mentor Worldwide LLC
  • Establishment Labs Holdings Inc.
  • Polytech Health & Aesthetics GmbH

第十四章 戰略建議

第十五章 查詢及免責聲明

Product Code: MX11203

Global breast reconstruction market is projected to witness a CAGR of 5.14% during the forecast period 2024-2031F, growing from USD 1.01 billion in 2023 to USD 1.51 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years. Growth in the global breast reconstruction market is driven by various factors such as the increasing prevalence of breast cancer among the global population and a growing number of breast reconstruction surgeries across the world. Technological advancements, the growing healthcare sector including the medical device industry and surgical industry along with increasing awareness campaigns by public and private organizations are the factors leading to the growth of this market globally. Moreover, favorable regulatory systems and reimbursement policies, the presence of several top players and collaborative venture activities, new entrants, and frequent product launches accelerate the growth of the global breast reconstruction market.

The global breast reconstruction market is undergoing robust growth primarily due to the increased prevalence of breast cancer among the global population. As this prevalence is increasing, there is an increase in the number of mastectomies performed every year. Breast reconstruction is the next essential step after mastectomy to restore the shape, size, symmetry, and contour of the breasts. Technological advancements in this industry such as the use of AI in performing breast reconstruction, increased research and development activities by the leading players further accelerating the global breast reconstruction market.

Frequent product launches by the market players along with a favorable regulatory framework play a pivotal role in boosting the global breast reconstruction market. There have been increased FDA approvals of breast implants, leading to improved medical conditions of the patients and surgical outcomes. Moreover, consistent collaboration activities such as mergers and acquisitions, partnerships, and distribution agreements between the organizations further propel the global breast reconstruction market.

For instance, in May 2022, GC Aesthetics, Inc., which is a leader in providing aesthetic solutions in the healthcare sector, announced the launch of "Nipple Areola Complex Reconstruction Implant" in partnership with FixNip LTD. This is implanted in just 15 minutes using minimally invasive surgery assists in enhancing patient satisfaction and contributes to the overall success of the breast reconstruction procedure.

Increasing Number of Breast Reconstruction Procedures

There has been a surge in the global breast reconstruction market due to the increasing prevalence of breast cancer worldwide. Breast cancer can lead to mastectomy, due to which patients are required to undergo breast reconstruction procedures. As there is increasing awareness among women regarding breast reconstruction options, there has been a significant increase in the number of breast reconstruction procedures.

For instance, an article, 'The International Awareness of Breast Reconstruction' published in the International Open Access Journal of the American Society of Plastic Surgeons, states that the number of breast reconstruction surgeries has significantly risen in recent decades. Additionally, with the growing awareness among women, it is anticipated that this will continue to rise in the forecast period as well. Moreover, technological advancements, favorable reimbursement policies, and an improved supportive regulatory framework further propel the global breast reconstruction market growth.

Technological Advancements

Growing demand for breast reconstruction treatment options led to increased research and development activities, which is further leading to innovation and technological advancements. Innovations such as the implementation of AI for breast reconstruction surgeries to improve surgical outcomes and the development of products that can enhance the aesthetic aspect of the surgery are driving market growth. Due to this, several leading players are consistently involved in developing innovative products in this market.

For instance, in April 2023, Establishment Labs Holdings Inc., which is a global medical technology company, announced the launch of its innovative product "Mia Femtech" for its Japan market, to bring advancement in the breast aesthetics market. Mia Femtech is the latest patented technology that can be executed in just 15 minutes via a minimally invasive procedure and does not require the use of general anesthesia. It gives natural and discreet results, and the patient can return to activities of daily life on the same day. Due to these innovative, beneficial technological advancements by the leading players, the global breast reconstruction market is expected to flourish.

Increased Demand for Implant-based Breast Reconstruction

Breast implant reconstructions hold a significant share in the market. Frequent technological advancements in the implants, faster procedure and recovery time, and simple procedures with fewer scars are some of the potential benefits of implant-based breast reconstruction. Due to this several market players are developing safe and efficient breast implants in their product portfolio.

For instance, in October 2023, MTF Biologics, which is a global nonprofit organization, announced that the U.S. FDA has approved an Investigational Device Exemption to commence a clinical investigation to validate the safety and efficacy of its latest launch implant, "FlexHD Pliable" for breast reconstruction. FlexHD Pliable is a human Acellular Dermal Matrix (ADM) implant for breast reconstruction. It is in the form of tissue that has been cut from a deeper layer of the dermis and afterward processed using an aseptic technique. This implant is the first ADM for breast reconstruction, that has been granted FDA approval to commence clinical trials. These innovative discoveries and product launches to enhance and expand growth in the implant-based breast reconstruction procedure are propelling the growth of the global breast reconstruction market.

Hospitals Hold a Major Share in the Global Breast Reconstruction Market

Among the end-user segment, hospitals hold a significant market share in the overall global breast reconstruction market. The increasing prevalence of breast cancer has led to an increased demand for breast reconstruction surgeries globally. Due to this, there has been a substantial increase in the requirement of hospitals to meet this growing requirement and for the timely execution of breast reconstruction surgeries. As a result, several countries are increasing the number of hospitals with proper surgical facilities.

For instance, in 2023, according to the American Hospital Association, there were 6,129 hospitals in the United States and more hospitals are under construction. Increased availability of highly efficient and safe breast implants, advanced technologies, and highly trained surgeons, along with the availability of end-to-end facilities for the patients, starting from assessment to follow-up, is leading to high demand for hospital-related services among the patients. This has led to the dominance of hospitals as an end-user segment.

North America Holds Significant Market Share

North America dominates the global breast reconstruction market, due to various factors such as the increasing cases of breast cancer in the region, which leads to mastectomy in most cases, due to which the demand for breast reconstruction is also on the rise. For instance, The American Cancer Society states that, the most common cancer in the U.S. is breast cancer. It states that in the year 2023, about 297,790 new cases of invasive breast cancer and approximately 55,720 new cases of Ductal Carcinoma In Situ (DCIS) were diagnosed among women in the U.S.

The increasing number of cases of breast cancer leads to an increase in mastectomy procedures that further leads to increased requirements for breast reconstruction. In addition, robust healthcare infrastructure, technological advancement in the region, favorable reimbursement policies, along with presence of major players such as Sientra, Inc. and Integra LifeSciences are other factors that are escalating the growth of this market in the region.

Future Market Scenario (2024-2031F)

The global breast reconstruction market is expected to grow in the future, due to several factors including the increasing prevalence of breast cancer, which increases the probability of mastectomies globally. Furthermore, technological advancements and innovation in breast reconstruction surgeries, will improve the quality of life of the patient and improve the surgical outcomes.

For instance, in January 2024, Establishment Labs Holdings Inc., which is a leading medical technology company, announced the launch of "Motiva Implants" for its China market. The Motiva Flora is a tissue expander implant, that is the only regulatory-approved expander in the world that uses radio-frequency technology. This product enhances breast reconstruction outcomes in the patients leading to increased patient satisfaction. Due to these frequent innovative launches by the leading players, the global breast reconstruction market is expected to flourish in the forecast period.

Key Players Landscape and Outlook

In the breast reconstruction market, several medical device manufacturers are consistently establishing strategic partnerships, and undergoing distribution agreements, which play an essential role in propelling the global breast reconstruction market's expansion. These partnerships enable companies to gain informative insights regarding market trends, access each other's knowledge, resources, markets, and technologies, and invest in research and development activities to bring safe and efficient breast reconstruction solutions such as breast implants. Distribution agreements enable companies to broaden their market presence at a global level. These collaborative ventures promote innovation, expedite product development and contribute to the enduring and robust growth of the global market.

For instance, in December 2022, Integra LifeSciences Holdings Corporation, which is a global leader in medical technology, announced the successful acquisition of Surgical Innovation Associates. This strategic acquisition is expected to support the company in bringing advancement and innovation in implant-based breast reconstruction procedures and contribute to improving patient outcomes.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Breast Reconstruction Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2.By Procedure
    • 4.2.1. Implant Reconstruction
      • 4.2.1.1.Silicone Breast Implants
      • 4.2.1.2.Saline Breast Implants
    • 4.2.2. Tissue Reconstruction
    • 4.2.3. Others
  • 4.3.Product
    • 4.3.1. Breast Implant
    • 4.3.2. Tissue Expander
    • 4.3.3. Acellular Dermal Matrix
    • 4.3.4. Other Products
  • 4.4.By End-user
    • 4.4.1. Hospitals
    • 4.4.2. Cosmetology Clinics
    • 4.4.3. Others
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.Europe
    • 4.5.3.Asia-Pacific
    • 4.5.4.South America
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Breast Reconstruction Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2. By Procedure
      • 5.1.2.1.Implant Reconstruction
      • 5.1.2.1.1.Silicone Breast Implants
      • 5.1.2.1.2.Saline Breast Implants
      • 5.1.2.2.Tissue Reconstruction
      • 5.1.2.3.Others
    • 5.1.3. By Product
      • 5.1.3.1.1.Breast Implant
      • 5.1.3.1.2.Tissue Expander
      • 5.1.3.1.3.Acellular Dermal Matrix
      • 5.1.3.1.4.Other Products
    • 5.1.4.By End-user
      • 5.1.4.1.Hospitals
      • 5.1.4.2.Cosmetology Clinics
      • 5.1.4.3.Others
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
      • 5.1.5.1.1.By Value
      • 5.1.5.1.2.By Volume
      • 5.1.5.2.By Procedure
      • 5.1.5.2.1.Implant Reconstruction
      • 5.1.5.2.1.1.Silicone Breast Implants
      • 5.1.5.2.1.2.Saline Breast Implants
      • 5.1.5.2.2.Tissue Reconstruction
      • 5.1.5.2.3.Others
      • 5.1.5.3.By Product
      • 5.1.5.3.1.Breast Implant
      • 5.1.5.3.2.Tissue Expander
      • 5.1.5.3.3.Acellular Dermal Matrix
      • 5.1.5.3.4.Other Products
      • 5.1.5.4.By End-user
      • 5.1.5.4.1.Hospitals
      • 5.1.5.4.2.Cosmetology Clinics
      • 5.1.5.4.3.Others
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3.Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4.South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5.Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6.Market Mapping, 2023

  • 6.1.By Procedure
  • 6.2.By Product
  • 6.3.By End-user
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Patent Landscape
  • 9.3.Regulatory Approvals
  • 9.4.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Allergan Aesthetics (AbbVie Inc.)
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Sientra, Inc.
  • 13.3.Medical Devices Business Services, Inc.
  • 13.4.RTI Surgical, Inc.
  • 13.5.Groupe SEBBIN SAS
  • 13.6.Integra LifeSciences
  • 13.7.GC Aesthetics
  • 13.8.Mentor Worldwide LLC
  • 13.9.Establishment Labs Holdings Inc.
  • 13.10.Polytech Health & Aesthetics GmbH

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 2.Global Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 3.Global Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 4.Global Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 5.Global Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 6.Global Breast Reconstruction Market Share (%), By Region, 2017-2031F
  • Figure 7.North America Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 8.North America Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 9.North America Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 10.North America Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 11.North America Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 12.North America Breast Reconstruction Market Share (%), By Country, 2017-2031F
  • Figure 13.United States Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 14.United States Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 15.United States Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 16.United States Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 17.United States Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 18.Canada Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 19.Canada Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 20.Canada Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 21.Canada Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 22.Canada Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 23.Mexico Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 24.Mexico Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 25.Mexico Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 26.Mexico Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 27.Mexico Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 28.Europe Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 29.Europe Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 30.Europe Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 31.Europe Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 32.Europe Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Breast Reconstruction Market Share (%), By Country, 2017-2031F
  • Figure 34.Germany Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 35.Germany Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 36.Germany Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 37.Germany Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 38.Germany Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 39.France Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 40.France Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 41.France Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 42.France Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 43.France Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 44.Italy Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 45.Italy Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 46.Italy Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 47.Italy Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 48.Italy Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 49.United Kingdom Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 50.United Kingdom Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 51.United Kingdom Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 52.United Kingdom Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 53.United Kingdom Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 54.Russia Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 55.Russia Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 56.Russia Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 57.Russia Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 58.Russia Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 59.Netherlands Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 60.Netherlands Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 61.Netherlands Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 62.Netherlands Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 63.Netherlands Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 64.Spain Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 65.Spain Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 66.Spain Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 67.Spain Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 68.Spain Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 69.Turkey Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 70.Turkey Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 71.Turkey Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 72.Turkey Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 73.Turkey Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 74.Poland Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 75.Poland Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 76.Poland Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 77.Poland Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 78.Poland Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 79.South America Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 80.South America Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 81.South America Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 82.South America Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 83.South America Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 84.South America Breast Reconstruction Market Share (%), By Country, 2017-2031F
  • Figure 85.Brazil Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 86.Brazil Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 87.Brazil Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 88.Brazil Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 89.Brazil Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 90.Argentina Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 91.Argentina Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 92.Argentina Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 93.Argentina Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 94.Argentina Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 95.Asia-Pacific Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 96.Asia-Pacific Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 97.Asia-Pacific Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 98.Asia-Pacific Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 99.Asia-Pacific Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 100.Asia-Pacific Breast Reconstruction Market Share (%), By Country, 2017-2031F
  • Figure 101.India Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 102.India Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 103.India Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 104.India Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 105.India Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 106.China Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 107.China Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 108.China Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 109.China Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 110.China Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 111.Japan Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 112.Japan Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 113.Japan Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 114.Japan Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 115.Japan Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 116.Australia Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 117.Australia Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 118.Australia Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 119.Australia Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 120.Australia Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 121.Vietnam Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 122.Vietnam Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 123.Vietnam Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 124.Vietnam Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 125.Vietnam Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 126.South Korea Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 127.South Korea Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 128.South Korea Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 129.South Korea Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 130.South Korea Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 131.Indonesia Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 132.Indonesia Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 133.Indonesia Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 134.Indonesia Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 135.Indonesia Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 136.Philippines Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 137.Philippines Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 138.Philippines Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 139.Philippines Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 140.Philippines Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 141.Middle East & Africa Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 142.Middle East & Africa Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 143.Middle East & Africa Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 144.Middle East & Africa Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 145.Middle East & Africa Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 146.Middle East & Africa Breast Reconstruction Market Share (%), By Country, 2017-2031F
  • Figure 147.Saudi Arabia Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 148.Saudi Arabia Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 149.Saudi Arabia Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 150.Saudi Arabia Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 151.Saudi Arabia Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 152.UAE Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 153.UAE Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 154.UAE Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 155.UAE Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 156.UAE Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 157.South Africa Breast Reconstruction Market, By Value, in USD Billion, 2017-2031F
  • Figure 158.South Africa Breast Reconstruction Market, By Volume, in Billion Units, 2017-2031F
  • Figure 159.South Africa Breast Reconstruction Market Share (%), By Procedure, 2017-2031F
  • Figure 160.South Africa Breast Reconstruction Market Share (%), By Product, 2017-2031F
  • Figure 161.South Africa Breast Reconstruction Market Share (%), By End-user, 2017-2031F
  • Figure 162.By Procedure Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163.By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023